Kewei Yu

机构：Fudan University, Huashan Hospital · ORCID：0000-0003-4267-2780

发表论文 23 篇 · 总被引 360 次 · h-index 11

代表论文

Roles of nicotinic acetylcholine receptor β subunits in function of human α4‐containing nicotinic receptors (2006 · The Journal of Physiology · 被引 75)
Dual functional roles of the MyD88 signaling in colorectal cancer development (2018 · Biomedicine & Pharmacotherapy · 被引 60)
Kanglaite injection combined with chemotherapy versus chemotherapy alone in the treatment of advanced non-small cell lung carcinoma (2014 · Journal of Cancer Research and Therapeutics · 被引 30)
Agonist-induced hump current production in heterologously-expressed human α4β2-nicotinic acetylcholine receptors (2008 · Acta Pharmacologica Sinica · 被引 25)
Efficacy and safety of trastuzumab emtansine (T-DM1) in the treatment of HER2-positive metastatic breast cancer (MBC): a meta-analysis of randomized controlled trial (2017 · Oncotarget · 被引 23)
Kinetics of desensitization and recovery from desensitization for human α4β2-nicotinic acetylcholine receptors stably expressed in SH-EP1 cells (2009 · Acta Pharmacologica Sinica · 被引 18)